| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/28/2009 | US7524499 Vascular endothelial growth factor fusion comprising fms-related tyrosine kinase 1 (Flt1 receptor ) and immunoglobulin components for use in identifying modulators for decreasing or inhibiting plasma leakage; treating eye disorders |
| 04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/28/2009 | US7524494 Degradation of hydrophobic ester pesticides and toxins |
| 04/28/2009 | US7524493 Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension |
| 04/28/2009 | US7524492 Insulin related transcription factor and uses thereof |
| 04/28/2009 | US7524491 Non human animals with human-glial chimeric brains |
| 04/28/2009 | US7524488 Interleukin-18 mutants |
| 04/28/2009 | US7524327 Light activated gene transduction using long wavelength ultraviolet light for cell targeted gene delivery |
| 04/28/2009 | CA2591550C Monitoring hybridization during pcr |
| 04/28/2009 | CA2418506C Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 04/28/2009 | CA2401727C Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 04/28/2009 | CA2390639C Process and composition for preparing a lignocellulose-based product, and the product obtained by the process |
| 04/28/2009 | CA2375450C Screening methods for altering circadian rhythm proteins |
| 04/28/2009 | CA2318984C Tumor tissue microarrays for rapid molecular profiling |
| 04/28/2009 | CA2283537C Vectors having enhanced expression, and methods of making and uses thereof |
| 04/28/2009 | CA2252493C .beta.-galactoside - .alpha. 2,6-sialyltransferase gene |
| 04/28/2009 | CA2220195C Therapeutic oligonucleotides targeting the human mdr1 and mrp genes |
| 04/28/2009 | CA2219988C Cd16-ii variants |
| 04/28/2009 | CA2212382C Cochleate delivery vehicles |
| 04/28/2009 | CA2197653C Delivery of nucleic acids |
| 04/28/2009 | CA2191978C Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 04/28/2009 | CA2133017C Process for producing desired substance using acetic acid-resistant recombinant escherichia microorganism |
| 04/28/2009 | CA1341595C Procedure for obtaining dna, rna, peptides, polypeptides, or proteins byrecombinant dna techniques |
| 04/23/2009 | WO2009052476A2 Maize stress-responsive nac transcription factors and promoter and methods of use |
| 04/23/2009 | WO2009052431A2 Cd19 binding agents and uses thereof |
| 04/23/2009 | WO2009052426A2 Oncolytic virus |
| 04/23/2009 | WO2009052389A1 Hematopoietic fingerprints: methods of use |
| 04/23/2009 | WO2009052377A1 Treatment of migraine headaches using antiestrogens |
| 04/23/2009 | WO2009052242A2 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 04/23/2009 | WO2009052214A2 Sequence analysis using decorated nucleic acids |
| 04/23/2009 | WO2009051827A1 Modulation of sodium channels by nicotinamide adenine dinucleotide |
| 04/23/2009 | WO2009051808A1 Quantitative trait locus (qtl) responsible for style length |
| 04/23/2009 | WO2009051801A2 Chemical inhibitors of inhibitors of differentiation |
| 04/23/2009 | WO2009051662A2 Lunasin-induced regulation of disease-related gene expression |
| 04/23/2009 | WO2009051659A2 Therapeutic sirna molecules for reducing vegfr1 expression in vitro and in vivo |
| 04/23/2009 | WO2009051439A2 Method of identifying agents which modulate the activity of calcium-activated chloride channel |
| 04/23/2009 | WO2009051344A2 A vector for expressing antibody fragments and a method for producing recombinant phage that displays antibody fragments by using the vector |
| 04/23/2009 | WO2009051290A1 Surface expression vector for fusion protein of myo-2 peptide multimer and myostatin, and microorganism transformed by thereof |
| 04/23/2009 | WO2009051289A1 Patatin-free potato plant |
| 04/23/2009 | WO2009051226A1 Method for production of stable mutant protein |
| 04/23/2009 | WO2009051220A1 Antibody capable of specifically binding to aβ oligomer, and use thereof |
| 04/23/2009 | WO2009051214A1 Nucleic acid amplification method, and reagent and reagent kit for use in the method |
| 04/23/2009 | WO2009051201A1 Anti-bst2 antibody |
| 04/23/2009 | WO2009051152A1 Polyketide synthase-nonribosomal peptide synthetase gene |
| 04/23/2009 | WO2009051109A1 Method of constructing cells with high productivity of foreign protein |
| 04/23/2009 | WO2009051108A1 Method for production of antibody |
| 04/23/2009 | WO2009051078A1 Therapeutic gene expression system |
| 04/23/2009 | WO2009050898A1 Therapeutic agent for colorectal cancer |
| 04/23/2009 | WO2009050730A2 Rnai mediated knockdown of numa for cancer therapy |
| 04/23/2009 | WO2009050498A2 Chimeric constructs for eukaryotic membrane expression in prokaryotic cells |
| 04/23/2009 | WO2009050484A1 Knockout mice for a p450 gene cluster |
| 04/23/2009 | WO2009050474A1 Immunogenic ompositions containing escherichia coli h7 flagella and methods of use thereof |
| 04/23/2009 | WO2009050390A2 Method for producing flu virus |
| 04/23/2009 | WO2009050388A1 Antibody against anthrax toxins |
| 04/23/2009 | WO2009050372A2 Compositions containing lipophosphoramides and use thereof in gene therapy |
| 04/23/2009 | WO2009049373A1 Modulation of plant cell wall deposition |
| 04/23/2009 | WO2009049351A1 Construct system and uses therefor |
| 04/23/2009 | WO2009049350A1 Expression system for modulating an immune response |
| 04/23/2009 | WO2009033027A3 Suppression of scn9a gene expression and/or function for the treatment of pain |
| 04/23/2009 | WO2009029665A3 Improved methods for protein production |
| 04/23/2009 | WO2009026233A3 Self assembling peptide systems and methods |
| 04/23/2009 | WO2009025527A3 Sirna of nf-kb p105 for inhibiting cell proliferation and migration and a composition comprising same |
| 04/23/2009 | WO2009020771A3 Rnai agents comprising universal nucleobases |
| 04/23/2009 | WO2009013468A3 Late blight resistance genes and methods |
| 04/23/2009 | WO2009013159A3 Acetyl-coa producing enzymes in yeast |
| 04/23/2009 | WO2009011828A3 Methods and compositions useful for modulating drug-induced impairment |
| 04/23/2009 | WO2009000736A3 F. oxysporum f.sp. melonis race 1,2-resistant melons |
| 04/23/2009 | WO2009000098A3 Sequence based engineering and optimization of single chain antibodies |
| 04/23/2009 | WO2008156500A9 Methods of inducing or increasing the expression of proteoglycans such as aggrecan in cells |
| 04/23/2009 | WO2008155139A3 Methods and means for the production of plants with improved stress resistance |
| 04/23/2009 | WO2008153725A3 Viral nanoparticle cell-targeted delivery platform |
| 04/23/2009 | WO2008148575A3 Increased production of a target product via stabilization of mrna |
| 04/23/2009 | WO2008147824A3 Hydroxymethyl substituted rna oligonucleotides and rna complexes |
| 04/23/2009 | WO2008143704A3 Engineered microorganisms for producing n-butanol and related methods |
| 04/23/2009 | WO2008138658A3 Pharmaceutical compounds comprising abasic oligonucleotides |
| 04/23/2009 | WO2008130629A3 Engineered nucleases and their uses for nucleic acid assembly |
| 04/23/2009 | WO2008124162A3 Substrate-selective co-fermentation process |
| 04/23/2009 | WO2008109350A4 Nucleic acid compounds for inhibiting il6 gene expression and uses thereof |
| 04/23/2009 | WO2008062310A3 Elimination of the bacteria that cause pierce's disease |
| 04/23/2009 | WO2008038287A3 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 04/23/2009 | WO2008010228A3 Photosyntheticorganisms and compositions and methods of generating same |
| 04/23/2009 | WO2007149069A3 Resistance to acetolactate synthase-inhibiting herbicides |
| 04/23/2009 | WO2007141737A3 Targeted gene expression for the treatment of primary tumors, and a therapeutic extension to the treatment of metastases. |
| 04/23/2009 | WO2007138198A3 Method for the extraction of one or several proteins present in milk |
| 04/23/2009 | WO2007106136A3 Method and apparatus for avalanche-mediated transfer of agents into cells |
| 04/23/2009 | WO2007093972A3 Methods for delivering materials into biological systems using sonic energy |
| 04/23/2009 | WO2007072224A8 Increasing levels of nicotinic alkaloids |
| 04/23/2009 | WO2007047741A3 Expression of rbap48 in memory and aging and methods related thereto |
| 04/23/2009 | WO2007041213A3 Methods for regulation of p53 translation and function |
| 04/23/2009 | WO2007038762A3 Penumbra nucleic acid molecules, proteins and uses thereof |
| 04/23/2009 | WO2007028121A3 Eg8798 and eg9703 polynucleotides and uses thereof |
| 04/23/2009 | WO2007027828A3 Insect resistant transgenic turf grass |
| 04/23/2009 | WO2007019426A3 A novel peptide involved in energy homeostasis |
| 04/23/2009 | WO2007014075A3 Rnai modulation of the rho-a gene in research models |
| 04/23/2009 | WO2007011857A3 Low pungency, long day onion |
| 04/23/2009 | WO2007005645A3 Materials and methods for the generation of fully 2'-modified nucleic acid transcripts |
| 04/23/2009 | WO2006135866A3 Pufa polyketide synthase systems and uses thereof |
| 04/23/2009 | WO2006133333A3 Stimulation of pancreatic b cell proliferation |
| 04/23/2009 | WO2006107387A3 Wound treatment device for photodynamic therapy and method of using same |
| 04/23/2009 | WO2006104891A3 Methods and genetic constructs for modification of lignin composition of corn cobs |